BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6855395)

  • 41. Selective management of early glottic cancer.
    Davis RK; Kelly SM; Parkin JL; Stevens MH; Johnson LP
    Laryngoscope; 1990 Dec; 100(12):1306-9. PubMed ID: 2243523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic value of histopathological parameters in epidermoid carcinoma of the vocal cords in T-1 stage].
    Barona R; Basterra J; Martorell MA; Garín L; Alvarez-Valdés R; Armengot M
    An Otorrinolaringol Ibero Am; 1992; 19(5):467-74. PubMed ID: 1443465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence-based review of treatment options for patients with glottic cancer.
    Hartl DM; Ferlito A; Brasnu DF; Langendijk JA; Rinaldo A; Silver CE; Wolf GT
    Head Neck; 2011 Nov; 33(11):1638-48. PubMed ID: 21990228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer of the glottis: prognostic factors in radiation therapy.
    Mantravadi RV; Liebner EJ; Haas RE; Skolnik EM; Applebaum EL
    Radiology; 1983 Oct; 149(1):311-4. PubMed ID: 6611940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in T2 glottic cancer.
    Harwood AR; DeBoer G
    Cancer; 1980 Mar; 45(5):991-5. PubMed ID: 7260851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx.
    Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
    Am J Otolaryngol; 1994; 15(4):250-7. PubMed ID: 7978023
    [No Abstract]   [Full Text] [Related]  

  • 47. [The prognostic significance of impaired vocal cord motility in patients with stage II glottic cancer treated with radiotherapy].
    Kowalska T; Reinfuss M; Walasek T; Dymek P; Weiss M; Skołyszewski J
    Otolaryngol Pol; 1997; 51(1):31-6. PubMed ID: 9518313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx.
    Gorphe P; Blanchard P; Temam S; Janot F
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3013-8. PubMed ID: 25218197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management of glottic carcinoma by primary irradiation with surgery in reserve.
    Stewart JG; Brown JR; Palmer MK; Cooper A
    Laryngoscope; 1975 Sep; 85(9):1477-84. PubMed ID: 1177639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence-based practice: management of glottic cancer.
    Hartl DM
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1143-61. PubMed ID: 22980690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glottic carcinomas: a retrospective study of 101 cases.
    Broniatowski M
    Ear Nose Throat J; 1985 Nov; 64(11):527-31. PubMed ID: 4064984
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery.
    Spector JG; Sessions DG; Chao KS; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Mar; 21(2):116-23. PubMed ID: 10091979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of vocal cord fixation with respect to treatment in cancers of the supraglottis and pyriform sinus.
    Spaulding CA; Gillenwater A; Constable WC; Hahn SS; Kersh CR
    Laryngoscope; 1987 Dec; 97(12):1450-3. PubMed ID: 3683056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx.
    Jakobsson PA
    Can J Otolaryngol; 1975; 4(5):885-92. PubMed ID: 1203794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic factors in T3,N0-1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy.
    Kowalski LP; Batista MB; Santos CR; Scopel A; Salvajolli JV; Torloni H
    Arch Otolaryngol Head Neck Surg; 1996 Jan; 122(1):77-82. PubMed ID: 8554750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
    Gainor DL; Marchiano E; Bellile E; Spector ME; Taylor JMG; Wolf GT; Hogikyan ND; Prince ME; Bradford CR; Eisbruch A; Worden F; Shuman AG
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):625-630. PubMed ID: 28608731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of cancer of the larynx. Analysis of success and failure.
    Shapshay SM; Hybels RL
    Otolaryngol Clin North Am; 1985 Aug; 18(3):461-8. PubMed ID: 4047668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors in squamous cell carcinoma of the larynx.
    Eiband JD; Elias EG; Suter CM; Gray WC; Didolkar MS
    Am J Surg; 1989 Oct; 158(4):314-7. PubMed ID: 2802033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic policy in stage I-II laryngeal cancer].
    Amiraliev NM
    Lik Sprava; 2002; (2):72-6. PubMed ID: 12073267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical and anatomopathological course of cancer starting in the vocal cords. Results of treatment].
    Szlezak L; Przybora LA
    Ann Otolaryngol Chir Cervicofac; 1983; 100(2):115-24. PubMed ID: 6847067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.